D61.02

Clinical Causes: Shwachman-Diamond syndrome is caused by genetic mutations, specifically in the SBDS gene. These mutations are inherited in an autosomal recessive pattern, meaning a child must inherit two copies of the mutated gene—one from each parent—to develop the syndrome. The exact reason for these genetic mutations is often unknown, but they disrupt the normal development and function of the bone marrow and pancreas.

Key Symptoms: Individuals with SDS may experience a range of symptoms, including: - Chronic anemia, leading to fatigue and weakness - Increased susceptibility to infections due to low white blood cell counts - Easy bruising and bleeding because of reduced platelets - Pancreatic insufficiency, resulting in malabsorption, diarrhea, and poor growth - Bone abnormalities, such as abnormal bone density or fractures - Delayed development and growth in childhood - Fatigue and general discomfort - Recurrent infections, especially in the lungs and skin

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Key steps include: - Blood tests to assess blood cell counts - Bone marrow biopsy to examine marrow health - Pancreatic function tests, including stool fat analysis - Genetic testing to identify mutations in the SBDS gene - Imaging studies may be used to evaluate bone structure and other potential abnormalities Diagnosis is often based on identifying characteristic symptoms coupled with laboratory and genetic findings.

Treatment Protocols: While there is no cure for Shwachman-Diamond syndrome, various treatments are aimed at managing symptoms and preventing complications: - Regular blood transfusions or growth factors to support blood cell production - Pancreatic enzyme replacement therapy to aid digestion - Nutritional support, including high-calorie diets and supplements - Antibiotics and other medications to prevent and treat infections - Monitoring for and addressing bone health issues, such as fractures or marrow failure - In some cases, hematopoietic stem cell transplantation may be considered for severe marrow failure - Supportive care and therapies to promote growth and development Patients often require a multidisciplinary team approach to address the diverse effects of the syndrome.